1. 19P Effects of CTLA-4 single nucleotide polymorphisms (SNPs) on toxicity of ipilimumab-containing regimens in patients with advanced stage melanoma. (December 2022) Authors: Joode, K.D.; Rojas Mora, A.; Van Schaik, R.; Zippelius, A.; Van der Veldt, A.A.M.; Gerard, C.L.; Läubli, H.; Michielin, O.A.; von Moos, R.A.F.; Joerger, M.; Levesque, M.P.; Aeppli, S.; Mangana, J.; Mangas, C.; Meyer, S.; Leoni-Parvex, S.; Mathijssen, R.H.; Metaxas, Y. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries. (December 2022) Authors: Cortellini, A.; Dettorre, G.; Dafni, U.; Aguilar Company, J.; Castelo-Branco, L.; Lambertini, M.; Gennatas, S.; Rogado, J.; Vinal Lozano, D.; Harrington, K.J.; Tsourti, Z.; Michielin, O.A.; Pommeret, F.; Brunet Vidal, J.M.; Tabernero, J.; Pentheroudakis, G.; Gennari, A.; Peters, S.; Romano, E.; P... Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 5P Tumor microenvironment cellular crosstalk predicts response to adoptive TIL therapy in melanoma patients. (December 2022) Authors: Dangaj, D.; Barras, D.; Ghisoni, E.; Chiffelle, J.; Orcurto, A.; Dagher, J.; Fahr, N.; Dafni, U.; Sempoux, C.; Michielin, O.A.; Trueb, L.; Harari, A.; Coukos, G. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗